Search database
LIST OPTIONS
Filter
9
Filtered Results: 9
Text search: Marissa Vicari
Featured
Language
Document type
No document type
4
Studies & Reports
3
Manuals
1
Guidelines
1
Authors & Publishers
et al.
6
Ovid
4
A. Armstrong
2
C. Irvine
2
J. M. Nagata
2
JAIDS Journal of Acquired Immune Deficiency Syndromes
2
M. Vicari
2
Unicef
2
World Health Organization
2
World Health Organization (WHO)
2
A. H. Sohn
1
A. Judd
1
A. L. Slogrove
1
Carlo Oliveras
1
et al
1
Hayley Gleeson
1
IAS
1
IPPF
1
Journal of Acquired Immune Deficiency Syndromes (JAIDS )
1
Journal of Acquired Immune Deficiency Syndromes (JAIDS)
1
L. Mofenson
1
M. Penazzato
1
M. Schomaker
1
M.-A. Davies
1
Marissa Vicari
1
Pata Pata Pata
1
PLOS Medicine
1
The Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration
1
Unitaid
1
Publication Years
Category
HIV & STI
1
Toolboxes
Treatment & Prevention
4
Children & Adolescents
4
General Aspects
4
Clinical Aspects, Treatment & Prevention
1
Opportunistic Infections
1
Co-Morbidities (except TB)
1
Epidemiology
1
Antiretroviral Treatment ART
1
Child Survival working Group Accessed: 18.10.2019

A Global Research Agenda for Pediatric HIV

M. Penazzato; C. Irvine; M. Vicari; et al Journal of Acquired Immune Deficiency Syndromes (JAIDS); Ovid (2018) CC
Supplement Article www.jaids.com J Acquir Immune Defic Syndr  Volume 78, Supplement 1, August 15, 2018

A Global Research Agenda for Adolescents Living With HIV

A. Armstrong; J. M. Nagata; M. Vicari; et al. Journal of Acquired Immune Deficiency Syndromes (JAIDS ); Ovid (2018) CC
Supplement Article J Acquir Immune Defic Syndr  Volume 78, Supplement 1, August 15, 2018 www.jaids.com
Supplement Article J Acquir Immune Defic Syndr  Volume 78, Supplement 1, August 15, 2018 www.jaids.com
Supplement Article www.jaids.com J Acquir Immune Defic Syndr  Volume 78, Supplement 1, August 15, 2018
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002514 March 1, 2018
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa. These guidelines update the recommendations that were first released i... more

Annex 3. Dosages of ARV drugs

World Health Organization (2019) C_WHO
Accessed: 19.10.2019
WHO and UNITAID in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group